DailyIQ
Last updated 1 hour ago

ALB·Albemarle Corporation

$.
+. (+.%)
High
$177.40
Open
$175.02
Market Cap
20.24B
52W High
$221.00
Low
$171.60
P. Close
$171.58
P/E
-
52W Low
$53.70
Fwd P/E
14.75
Mean Target
-
Technical Score (1D)
59
BUY
News Sentiment
59
BULLISH
Albemarle (ALB) is experiencing increased market attention, with underlying factors driving heightened investor interest. This focus suggests a need to review the company's fundamentals and prospects. In a recent development, RBC Capital Markets lifted its price target on ALB to $257 from $253, while maintaining an 'Outperform' rating. This analyst sentiment indicates a positive outlook for ALB, reflecting confidence in its market position and future performance. Investors will want to watch for further commentary on the specific catalysts driving this analyst optimism and how they might impact ALB's trajectory in the coming days.
Earnings Summary
Albemarle Corporation is a global producer of essential specialty chemicals, with a primary focus on the energy storage and specialty solutions markets. The company's operations are centered around lithium compounds vital for the burgeoning electric vehicle and consumer electronics sectors, alongside bromine-based chemicals and catalysts for the refining industry. Albemarle operates within the Basic Materials sector, specifically in the Specialty Chemicals industry, positioning itself to benefit from global trends in energy transition and advanced material applications. The company's strategic focus on lithium places it at the forefront of supplying critical components for battery technology. Examining Albemarle's recent earnings performance reveals a mixed trend in the most recent quarters. For Q4 2025, the company reported an actual EPS of -0.53 against an estimate of 0.10172, and revenue of $1.43 billion against an estimate of $1.35 billion. This followed Q3 2025 where actual EPS was -0.19 compared to an estimate of -0.8767, with revenue at $1.31 billion versus an estimate of null. Prior to this, Q2 2025 showed actual EPS of 0.11 against an estimate of -0.81424 and revenue of $1.33 billion versus an estimate of null. The preceding quarter, Q1 2025, had actual EPS of -0.18 against an estimate of -0.67971 and revenue of $1.08 billion versus an estimate of null. This pattern indicates significant volatility in earnings per share, with several quarters missing analyst expectations, while revenue has shown more consistent, albeit fluctuating, performance. Historically, Albemarle's year-over-year growth trajectory has been subject to considerable swings, reflecting the dynamic nature of the specialty chemicals and energy storage markets. The company has demonstrated an ability to beat revenue estimates in some periods, even when EPS has fallen short of expectations, suggesting potential operational strengths in sales generation. However, the recent earnings history shows a pattern of EPS misses against analyst estimates, particularly in the latter half of 2025, though Q1 2026 saw a significant beat with actual EPS of $2.95 against an estimate of $1.31347 and revenue of $1.43 billion against an estimate of $1.31739512. Recent news highlights Albemarle being identified as a "momentum anomaly" stock, supported by a strong Zacks Momentum Style Score 'A', suggesting potential for outperformance driven by price trends and earnings estimate revisions. Analyst sentiment appears positive, with Scotiabank initiating coverage with a favorable rating and price target. Furthermore, geopolitical developments, such as the U.S. Pentagon's push to reduce reliance on Chinese rare earth materials by a January 2027 deadline, underscore the strategic importance of companies like Albemarle in securing diversified supply chains for critical elements. Investors will be watching for Albemarle's ability to sustain its positive EPS momentum from Q1 2026, particularly in light of the analyst optimism and the potential benefits from evolving global supply chain dynamics for critical minerals. Key will be the company's performance in its energy storage segment and its capacity to navigate the complex market conditions influencing lithium demand and pricing.

EPS

EstBeatMiss
$-1.46$-0.20$1.06$2.31$3.57Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$2.99 - -
Q1'26$1.31$2.95+124.6%
Q4'25$0.10$-0.53-621.0%
Q3'25$-0.88$-0.19+78.3%
Q2'25$-0.81$0.11+113.5%
Q1'25$-0.68$-0.18+73.5%

Revenue

EstBeatMiss
$1.0B$1.2B$1.3B$1.5B$1.7BQ1'25Q2'25Q3'25Q4'25Q1'26Q2'26
QtrEstActual+/−
Q2'26$1.6B - -
Q1'26$1.3B$1.4B+8.5%
Q4'25$1.4B$1.4B+5.7%
Q3'25 - $1.3B -
Q2'25 - $1.3B -
Q1'25 - $1.1B -

Market Data

ALB Stock Snapshot

ALB is currently trading at $175.96, giving Albemarle Corporation a market cap of 20.24B. Today's range spans $171.60–$177.40, with shares opening at $175.02 and moving up $4.38 (2.6%) from the prior close. DailyIQ's technical score sits at 59/100 (HOLD) with a news sentiment reading of 59/100.

Over the past year ALB has traded between $53.70 and $221.00 - the current price is +227.7% off the 52-week low and -20.4% from the high.

ALB trades at $175.96 (in the upper portion of its 52-week range within $53.70–$221.00) - and the HOLD signal (59/100) reflects a market that's fairly priced relative to near-term expectations rather than one that's mispriced in either direction. At 20.24B in Basic Materials market cap, neutral sentiment (59/100) confirms the lack of near-term narrative catalyst. The thesis is intact; the timing is patient.

In neutral phases, large-cap Basic Materials names like ALB are often where sector rotation debates play out quietly — at 20.24B in capitalization, the stock receives incremental allocation from funds reducing mega-cap exposure without the volatility of a small-cap entry. The 59/100 (HOLD) and neutral sentiment (59/100) at $175.96 (in the upper portion of its 52-week range) describe a stock that is being considered rather than avoided.

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

0+ articles
Loading latest news…